Impact of hypertension and renin–angiotensin system inhibitors in aortic stenosis
Article first published online: 7 OCT 2013
© 2013 Stichting European Society for Clinical Investigation Journal Foundation. Published by John Wiley & Sons Ltd
European Journal of Clinical Investigation
Volume 43, Issue 12, pages 1262–1272, December 2013
How to Cite
Eur J Clin Invest 2013; 43 (12): 1262–1272
- Issue published online: 19 NOV 2013
- Article first published online: 7 OCT 2013
- Accepted manuscript online: 3 SEP 2013 01:27AM EST
- Manuscript Accepted: 29 AUG 2013
- Manuscript Received: 21 MAY 2013
- Canadian Institutes of Health Research. Grant Number: MOP-114997
- Foundation of the Québec Heart and Lung Institute
- International Chair of Cardiometabolic Risk, Québec, Québec
- Fonds de Recherche en Santé du Québec (FRSQ), Montreal
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.